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Poster Presentation Abstracts 137case application of the customized MPBB in pelvic Pemberton osteotomy shows a
sufficient compressive strength and wonderful biological activity which demon-
strates the good clinical effect. As such, this novel Bioglass-based graft material
might be a novel alternative in the reconstructions of hard tissue, especially for
use in application that require high load bearing implant materials.
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SCREENING OF OSTEOPOROSIS-RELATED PROTEIN MARKERS IN SERUM
Yaqian Hu, Zhuojie Zhao, Zhuojing Luo, Liu Yang
Xijing Hospital, The Fourth Military Medical University, China
Objective: Screening the serum markers which can reflect the development of
early stage of postmenopausal osteoporosis through protein ship.
Methods: Twenty 3-month-old female SD rats were randomly divided into sham
operation control group (Sham) and ovariectomy group (OVX), nZ10. The bone
mineral density (BMD) of distal femur and dynamic parameters of cancellous
bone morphology of the two groups rats were measured by micro CT at the end
of 2,4,6,8 weeks after operation. The blood of the two groups’ rats was taken
from angular vein at the same time. Using protein microarray to detect the con-
centration of 27 protein factors.
Results: Micro-CT examination showed that the BMD, BV/TV, Tb.Th, Tb.Sp of OVX
group rats began to decrease and Tb.N began to increase at the end of 4 weeks,
however there were no obvious changes in Sham group; there was significant dif-
ference between OVX and Sham groups by eighth weeks(P<0.05). Through the
detection of protein chip we found that IFNg of OVX group increased at 4th weeks
and b-NGF increased at 6th weeks after operation, there was significant difference
between OVX and Sham groups by eighth weeks (P<0.05).
Conclusion: The concentrations of IFNg and b-NGF began to increase at the early
stage of postmenopausal osteoporosis. Both of them are likely to be used as new
type of molecular markers in the diagnosis of the early stage of postmenopausal
osteoporosis.
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TETRAMETHYLPYRAZINE PROTECTS AGAINST APOPTOSIS THROUGH
PROMOTING AUTOPHAGY IN MESENCHYMAL STEM CELLS AND IMPROVES BONE
MASS IN GLUCOCORTICOID-INDUCED OSTEOPOROSIS RATS
Long Wang, Hongyang Zhang, Liu Yang, Zhuojing Luo
Xijing Hospital, The Fourth Military Medical University, China
Background: Glucocorticoids are widely used in clinic and have various adverse ef-
fects on bone cells leading to glucocorticoid-induced osteoporosis (GIOP). Excess
glucocorticoids could induce apoptosis of bone marrow-derived mesenchymal
stem cells (BMSCs) which play an important role in bone formation and skeletal ho-
meostasis. Tetramethylpyrazine (TMP), extracted from Chuanxiong which is one of
the most recognized traditional medicine, has been reported to have the anti-
apoptosis property.
Subjects and Methods: Here we tested whether TMP had a protective effect on
BMSCs under glucocorticoids exposure in vivo and in vitro. Fifty 4-month-old fe-
male Sprague-Dawley rats weighing 22318.5 g were obtained. Ten of them
were used to isolate BMSCs. We treated BMSCs with different concentrations of
TMP (50, 100, 200 mM) and exposed them to 106 M dexamethasone (Dex) for
48 h in vitro. The Cell Counting Kit-8 was used to measure cell viability. Cell
apoptosis was assessed by Annexin V/PI double staining and TUNEL staining.Transmission electron microscopy and western blot analysis were used to detect
the level of autophagy. Forty female SD rats were administered intraperitoneally
with either distilled water as the control group (nZ10) or 5 mg/kg prednisolone
as the GIOP group (nZ30) daily for 12 weeks. One week after the first administra-
tion, the 30 rats of the GIOP group were randomly divided into three experimental
groups of ten rats per group. The rats were injected intraperitoneally respectively
with sesame oil (as a vehicle control), 5 mg/kg or 20 mg/kg body weight of TMP
daily for 12 weeks. Calcein double labeling and micro-CT scanning were used to
monitor bone mass.
Results: Our data showed that TMP inhibited Dex-induced cytotoxicity and pro-
tected BMSCs from apoptosis. Interestingly, further results demonstrated that
TMP alleviated BMSCs apoptosis by promoting autophagy via AMPK/mTOR pathway.
In addition, calcein double labeling and micro-CT scanning indicated that 12 weeks
of TMP administration augmented bone formation and protected the trabecular
bone mass in GIOP rats. We also discovered that the first passage BMSCs isolated
from TMP treatment group showed lower apoptosis rate than GIOP group.
Discussion and Conclusion: Excess glucocorticoids are responsible for the
negative effects on BMSCs survival and function, and the defective BMSCs
would result in a reduction of osteogenesis and bone formation, and finally
contribute to bone loss in GIOP. For the first time we found that TMP could pro-
long BMSCs survival under excess glucocorticoids exposure by preserve viability
and inhibit apoptosis via promoting autophagy dependent on AMPK/mTOR
pathway in vitro. In vivo TMP administration increased bone formation and pre-
vented bone mass decrease in GIOP rats, and the protection on BMSCs against
apoptosis offered by TMP in GIOP state may be responsible for its anti-osteopo-
rosis effects. In conclusion, our findings suggested that TMP treatment and
regulation on BMSCs might be considered as a promising strategy for preventing
and treating GIOP.
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BLOCKING HYPOXIA-INDUCED CXCR4 BY AMD3100 INHIBITS PRODUCTION OF
OA ASSOCIATED CATABOLIC MEDIATORS IL-1b AND MMP-13
Pengcui Li a, Lei Wei a,b, Xiaochun Wei a
aDepartment of Orthopaedics, The Second Hospital of Shanxi Medical University,
China
bDepartment of Orthopaedics, Warren Alpert Medical School of Brown University,
China
Binding of the chemokine SDF-1 to its receptor CXCR4 results in receptor activation
and the subsequent release of matrix metalloproteinases that contribute to
osteoarthritis cartilage degradation. As hypoxia is a defining feature of the
chondrocyte microenvironment, the present study investigated the possible
mechanism through which SDF-1 induces cartilage degradation under hypoxic
conditions. To do this, osteoarthritis chondrocyte cultures and patient tissue
explants that pretreated with the CXCR4 inhibitor AMD3100, were treated with
SDF-1. We discovered that hypoxic conditions significantly elevated the expression
of CXCR4 in osteoarthritic chondrocytes relative to normoxic conditions. Further-
more, SDF-1 elevated MMP-13 mRNA levels and proteinase activity. It also elevated
the mRNA and protein levels of Runx2, and induced the release of glycosamino-
glycans and the inflammatory cytokine IL-1b. In contrast, such changes did not
occur to an appreciable degree in cells that were pretreated with AMD3100. Our
results demonstrate that even under hypoxic conditions where CXCR4 is signifi-
cantly elevated by chondrocytes, AMD3100 effectively blocks this receptor and
protects chondrocytes from osteoarthritis induced catabolism, suggesting that the
successful inhibition of CXCR4 may be an effective approach towards osteoarthritis
treatment.
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